Company profile
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Privately held: no public share price
Assets
(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | ALK / ROS1Small molecule | Non-Small Cell Lung Cancer | |
| Phase 3 | MEK1/2Small molecule | Non-Small Cell Lung Cancer | |
| Phase 2 | BCL-2Small molecule | Acute Myeloid Leukemia | |
| Phase 1 | BCL-2Biologic (subtype unspecified) | Acute Myeloid Leukemia |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.